What Johnson Allsopp Diabetes Management Actually Does
Johnson Allsopp Diabetes Management is a diabetes care service operated by Johnson Allsopp, a UK-based healthcare company. They work primarily with pharmacy groups and GP practices to deliver population-level diabetes management. The model is built around remote patient monitoring, regular medication reviews, structured education programs, and coordination between pharmacists and primary care teams. I found out about them through a colleague who runs a small independent pharmacy cluster. They were trying to hit HbA1c targets across a register of roughly 400 diabetes patients and didn't have the staffing to do it properly. Johnson Allsopp stepped in with a service agreement that included quarterly clinical reviews, a telephone-based check-in program, and a digital platform for tracking patient outcomes. It wasn't cheap, but it cut their average time spent on diabetes reviews from about 45 minutes per patient down to maybe 15 minutes of hands-on work.
Getting Started with Johnson Allsopp Diabetes Management
The first step is figuring out if this service actually fits your situation. Johnson Allsopp typically works with pharmacy chains, integrated care systems, and larger GP networks. A sole practitioner running a one-shop pharmacy won't find much value here. Their model relies on volume and data aggregation to make the economics work. If you're serious about it, you reach out to their business development team directly. There's no public sign-up page or download link. The process usually involves an initial consultation where they assess your patient population, review your current clinical governance setup, and propose a tailored service agreement. Expect that conversation to take about an hour. You'll need to provide anonymised patient data upfront so they can build a baseline report. What they deliver depends on the contract. The standard package includes:
Annual medication reviews for every patient on the register. Quarterly HbA1c trend analysis and flagging of deteriorating cases. A dedicated clinical pharmacist or diabetes specialist nurse assigned to your cohort.
Get the Full Details
Access to their management dashboard, which shows real-time metrics on target attainment and risk stratification. Education materials and group session support for newly diagnosed patients. I used this setup for about eight months last year. The dashboard was the part that actually changed how I worked. Instead of chasing patients reactively when their results came back bad, I could see who was trending upward three months in advance. That gave me time to intervene before complications set in. The turnaround time for getting patients into the system was roughly two to three weeks from contract signature, assuming your IT infrastructure can handle the data sharing requirements.
How It Works in Practice
The workflow is straightforward once you're set up. Patients are stratified into risk bands based on HbA1c levels, comorbidities, and medication complexity. High-risk patients get the most frequent contact. Medium and low-risk patients are checked less often but remain on the radar through automated alerts when results change. Medication reviews are conducted either over the phone or through scheduled video appointments. Pharmacists on the Johnson Allsopp team have access to prescription histories and laboratory results through agreed data-sharing protocols. They don't make prescribing decisions independently, but they flag recommendations that get reviewed by the patient's GP or practice pharmacist. The whole feedback loop usually takes about five to seven working days. One thing nobody tells you about this service is how much it depends on your existing data quality. If your practice registers are messy, if patient records are split across multiple systems, or if you're still doing paper-based HbA1c tracking, the dashboard becomes almost useless. I learned this the hard way. When we first onboarded, about 30% of our patient records had incomplete medication lists. The Johnson Allsopp team spent the first six weeks just cleaning data before the clinical work could really start. That delay ate into our budget with no visible output.
The workaround was to dedicate two staff members for a full week to reconcile records before the service went live. We cross-referenced pharmacy dispensing data against the electronic health record and flagged discrepancies. Once we got to a clean baseline, the service worked exactly as described. Without that prep work, we were getting reports on stale data and missing genuinely deteriorating patients because their records hadn't been updated since 2021.
What They Don't Cover
Johnson Allsopp Diabetes Management isn't a substitute for clinical care. It's a management and coordination service. They won't replace your pharmacist. They won't take over acute decision-making. If a patient presents with DKA symptoms or severe hypoglycaemia, you're still dealing with that yourself through the usual emergency pathways. They also don't handle Type 1 diabetes education in depth. Their model is heavily oriented toward Type 2 population management. If you're running a clinic with a significant Type 1 or maturity-onset diabetes of the young population, you'll need supplementary services elsewhere. I found this out when one of our Type 1 patients was quietly dropped from the program after the initial assessment. The team said they didn't have the clinical expertise in their network for that cohort. Fair enough, but it should have been flagged upfront rather than discovered months into the contract. The cost structure is another limitation worth mentioning. Based on what I paid, you're looking at roughly £80 to £150 per patient per year, depending on the level of service and the size of your register. Larger registers get volume discounts, but smaller ones pay a premium. If you're managing fewer than 200 diabetes patients, the economics don't usually work out in your favour unless you're part of a buying group or shared service arrangement.
Alternatives to Consider
If Johnson Allsopp doesn't fit, there are other options. Community Pharmacy Diabetes Services offered through NHS contracts can provide similar functions at lower cost, though the scope is narrower and the timelines longer. Some larger pharmacy groups like LloydsPharmacy and Boots run their own diabetes management programs that may be more flexible for smaller operators. For practices that want something more integrated, the Enhanced Service frameworks available through NHS England include diabetes-specific elements that don't require an external provider. I ended up combining Johnson Allsopp with an internal pharmacy-led review program. Their dashboard identified the patients who needed attention, and my team handled the face-to-face consultations for the most complex cases. That hybrid approach got us from a 42% target attainment rate to 67% within twelve months. Not perfect, but a meaningful improvement without outsourcing the entire relationship. The service has held up reasonably well over the contract period. Support responsiveness varies depending on which region you're assigned to. Our dedicated account manager was generally available within 24 hours for urgent queries, though routine requests often waited three to five working days. It's not ideal, but it's within the range I'd expect from any outsourced clinical service. If you go in with realistic expectations about turnaround times and data requirements, Johnson Allsopp Diabetes Management can be a workable addition to your practice infrastructure. If you need it to magically fix poor underlying systems, it won't.
